#ATMPs
So many acronyms, so many different manufacturing problems. Robert Dream sorts the ADCs from the AOCs from the ATMPs, and explains why no single development strategy covers them.
Comparing Advanced Modality Needs, Part 1: Manufacturing
ADCs, AOCs, ATMPs, cell and gene therapies, and oligonucleotide therapeutics represent distinct but interconnected approaches to precision medicine. Lets take a closer look at their manufacturing...
www.bioprocessonline.com
November 16, 2026 at 6:54 PM
TEAM V V
GRACIOUSLY
WLCMS THIS UPG DOJ

SUMMON TO
one ajitdoval modiran bjp clt ctn
mafia

OVR PANNU MURDER ATMPS

BUT UPG MUST ENSURE/CONCLUDE IT RIGHTLY NOT JUST EYEWASH

on.rt.com/dwi6
US court summons Ajit Doval, ex-RAW chief in Pannun case
US court issues summons to India’s NSA Ajit Doval and ex-RAW chief Samant Goel in a civil lawsuit filed by Sikh separatist Gurpatwant Singh Pannun
on.rt.com
November 11, 2026 at 1:06 AM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
November 4, 2026 at 5:41 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/tmQva7V
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
November 4, 2026 at 5:41 PM
#apaperaday Today's pick is a call for a roadmap to support the development of advanced medicinal productis (ATMPs) in Europe by Eldere et al in Lancet Regional Health Europe. 10.1016/j.lanepe.2026.101688
November 2, 2026 at 7:21 AM
ATMPs offer therapeutic options for rare diseases. They include gene therapy and ex vivo modified cell therapies and involve substances of human origin. This is why regulation is more complex and why often costs are higher.
November 2, 2026 at 7:25 AM
Not only for ATMPs but also other very rare disease treatments, centralized reimbursement has been proposed to improve access to eligible patients. Hopefully one day. I appreciate the honest call for action, where authors outline which ideas, while in principle good, are unlikely to be realized.
November 2, 2026 at 7:40 AM
For rarer disease there is often no commercial incentive but expert university hospitals have shown to be able to produce ATMPs for such diseases. However, due to lack of a flexible European regulatory framework and differences between member states, patients are at risk of missing out.
November 2, 2026 at 7:26 AM
Authors call for a decentralized system for ATMPs applying to very small groups, while for larger groups a hub and spoke model can be used, where expert hospitals produce the ATMP for a group of treating hospitals. Production and treatment needs to be done in expert centers.
November 2, 2026 at 7:29 AM
🧬What ethical challenges arise in Advanced Therapy Medicinal Products (ATMP) research, and how can resolving them become an advantage?

Today, @erdera.bsky.social Ethics & Regulatory Webinar with Joana Namorado

📅 13:00 CET
💻 Online
🔗 loom.ly/lZ8lmm8
#RareDiseases #ATMPs #ERDERA #Research #CNAG
November 2, 2026 at 8:15 AM
The Spanish Approach to Supporting the Development of SoHO Preparations, ATMPs, and Other SoHO-Based Products Under the New EU Regulation www.sciencedirect.com/science/arti... #hvhebron #hemat
October 28, 2026 at 10:32 AM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
October 21, 2026 at 6:19 PM
Registration is now open for Medical Law and Legal Aspects of ATMPs, an online course from the Swedish National ATMP Research School, hosted by Lund University, 8-12 February 2027.

Learn more and register:
lnkd.in/d5cBjtky
October 22, 2026 at 4:21 AM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
October 21, 2026 at 6:19 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
October 21, 2026 at 6:19 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
October 21, 2026 at 6:19 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
www.labroots.com
October 21, 2026 at 6:19 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
October 21, 2026 at 6:19 PM
Protect ATMPs and cell culture biotherapeutics from batch failures and delays with an EP 2.6.7 (12.2)-aligned NAT workflow for rapid mycoplasma testing. buff.ly/pBuVESG
Rapid Mycoplasma Detection in Cell Culture and Bioprocessing
buff.ly
October 21, 2026 at 6:19 PM